Activ Surgical Announces FDA Clearance for ActivSight Intraoperative Imaging Module

Activ Surgical announced the U.S. Food and Drug Administration (FDA) 510(k) clearance of the company’s ActivSight Intraoperative Imaging Module for enhanced surgical visualization.

Metrex Surface Disinfectant Portfolio Secures EPA Approval

The U.S. Environmental Protection Agency (EPA) has approved all eight surface disinfectant products made by an infection prevention leader, Metrex, as effective against SARS-CoV-2, the novel coronavirus that causes COVID-19.

Olympus Supports Safety Actions Regarding Surgical Smoke

Olympus has announced its support of The Joint Commission’s recommended safety actions for managing the hazards of exposure to surgical smoke for health care staff in operating rooms.

Exofin Fusion Redesign Receives FDA Approval

Chemence Medical, a leader in medical cyanoacrylate devices and products, announced the U.S. Federal Drug Administration’s (FDA) 510(k) approval of the company’s redesigned exofin fusion skin closure system.

UVC Disinfection Market Trending Up

By John Wallace

The ultraviolet disinfection market includes a wide range of applications across many industries. The health care segment of the market continues to show growth and growth potential. It is one segment that is pushing the overall market to new heights.

A MarketWatch News report sees the market reaching $5 billion in the near future.

“The global ultraviolet disinfection equipment market is expected to exceed more than $5 billion by 2024 at a compound annual growth rate (CAGR) of 14% during the period 2018-2024,” according to MarketWatch News. “The UV disinfection equipment market would garner revenue of $3.6 billion by 2020. The significance of different disinfection methodology like UV disinfection is growing by the day, as these strategies are higher than typical chemical based disinfection.”

Some driving factors for the market are value effectiveness as compared to alternative new disinfection ways and new government initiatives for UV disinfection, according to the report.

A BCC Research report also predicts continued market growth.

“The global market for UV disinfection equipment should grow from nearly $2.1 billion in 2018 to $4.4 billion by 2023 with a compound annual growth rate (CAGR) of 16.2% for the period of 2018-2023,” according to the report.

Tru-D Smart UVC President and CEO Chuck Dunn also has a positive forecast for the market.

“The UVC disinfection market has grown exponentially in the past few years. Tru-D was the first no-touch UVC disinfection device on the market in 2007. Today, the market has grown, and there are several companies that offer various types of UVC disinfection technologies,” Dunn said.

Dunn said research is among the factors that have propelled the market in recent years.

“As more evidence-based research is becoming available on UVC disinfection, including the first and only randomized clinical trial, the ‘BETR-Disinfection study,’ which was published in 2017 in The Lancet, hospitals are realizing the importance of and need for enhanced room disinfection. Notable researchers in infection control and hospital epidemiology have begun to stress the need for no-touch disinfection technology, which has driven acceptance of UVC robots in prestigious health care systems and hospitals throughout the U.S. Further, hospital reimbursements for infections also play a role in the decision to implement UVC disinfection technology,” Dunn said.

He predicts continued growth for the health care segment of the UVC disinfection market.

“As more evidence of UVC disinfection’s efficacy becomes available, enhanced terminal room disinfection strategies will likely become a standard of care for all hospitals,” Dunn said.



Submit a Comment

Your email address will not be published. Required fields are marked *